瑞普生物(300119.SZ)：第三季度净利润同比上升23.02%

Core Insights - The company reported a revenue of 837 million yuan for Q3 2025, representing a year-on-year increase of 1.44% [1] - The net profit attributable to shareholders was 106 million yuan, showing a year-on-year growth of 23.02% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 81.54 million yuan, reflecting a year-on-year increase of 7.64% [1]